Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123119) titled 'A single-center, randomized, open-label, two-period, two-sequence crossover clinical study to evaluate the effect of food on the pharmacokinetic characteristics of CMS-D001 tablets in healthy participants' on April 22.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University
Condition:
Pharmacokinetics of CMS-D001 tablets
Intervention:
A Group (Fasting - Postprandial):CMS-D001 tablet 100 mg, single oral administration. Fasting administration in the first cycle, postprandial (high-fat meal) administration in the second cycle.
Recruitme...